Omarigliptin Mitigates 6-Hydroxydopamine- or Rotenone-Induced Oxidative Toxicity in PC12 Cells by Antioxidant, Anti-Inflammatory, and Anti-Apoptotic Actions.

Gouda, Noha A; Cho, Jungsook

Gouda, Noha A; Cho, Jungsook.

Afiliación

Gouda NA; College of Pharmacy and Integrated Research Institute for Drug Development, Dongguk University-Seoul, 32 Dongguk-ro, Ilsandong-gu, Goyang 10326, Gyeonggi, Korea.
Cho J; College of Pharmacy and Integrated Research Institute for Drug Development, Dongguk University-Seoul, 32 Dongguk-ro, Ilsandong-gu, Goyang 10326, Gyeonggi, Korea.

Antioxidants (Basel) ; 11(10)2022 Sep 28.

Article en En | MEDLINE | ID: mdl-36290663

Palabras clave

PC12 cells; Parkinson's disease; apoptosis; drug repurposing; heme oxygenase-1; nuclear factor erythroid 2-related factor 2; nuclear factor-kappaB; omarigliptin; oxidative stress

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Antioxidants (Basel) Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Antioxidants (Basel) Año: 2022 Tipo del documento: Article